Europe — EMA
Glucose Baxter
Glucose Baxter is an EU‑marketed IV glucose monohydrate solution used for rapid carbohydrate supplementation and hypoglycemia treatment.
Request sourcing
What is Glucose Monohydrate?
Glucose Baxter is an intravenous preparation containing the active ingredient glucose monohydrate; the specific strength and dosage form are not disclosed. Marketed in the European Union, this product provides a sterile source of glucose for infusion in clinical settings where rapid carbohydrate supplementation is required.
What is Glucose Monohydrate used for?
Glucose Baxter is administered intravenously to address clinical situations that require immediate glucose delivery. It is commonly employed in the following contexts:
- Treatment of hypoglycemia when oral glucose is not feasible. - Provision of caloric support during surgery or critical illness. - Management of patients receiving parenteral nutrition. - Support during diagnostic procedures that require fasting. - Stabilization of blood glucose levels in patients with insulin therapy adjustments.
What are the side effects of Glucose Monohydrate?
Side effects associated with intravenous glucose administration can vary in frequency and severity.
Common: - Mild hyperglycemia - Local irritation at the infusion site - Nausea or vomiting - Headache - Transient electrolyte shifts
Serious: - Severe hyperglycemia leading to osmotic diuresis - Hypersensitivity reactions including rash or anaphylaxis - Fluid overload and pulmonary edema - Metabolic acidosis in susceptible patients
What precautions apply to Glucose Monohydrate?
When using Glucose Baxter, healthcare professionals should consider several precautionary measures:
- Assess baseline blood glucose and monitor levels frequently during infusion. - Adjust dosage in patients with renal or hepatic impairment. - Use caution in individuals with known hypersensitivity to glucose solutions. - Evaluate fluid status to avoid overload, especially in heart failure. - Review electrolyte balance, particularly potassium and sodium, before and during therapy. - Ensure proper aseptic technique to prevent catheter-related infections.
What does Glucose Monohydrate interact with?
Glucose Baxter may interact with other agents administered intravenously.
Avoid: - Co-administration with high-dose insulin without close glucose monitoring. - Simultaneous infusion of potassium chloride solutions, which can precipitate.
Use with caution: - Concurrent use of diuretics that affect electrolyte balance. - Administration alongside other hyperosmolar solutions. - Combination with medications that alter glucose metabolism, such as glucocorticoids. - Use in patients receiving total parenteral nutrition containing dextrose.
Frequently asked questions
What is the active ingredient in Glucose Baxter?+
How is Glucose Baxter administered?+
In which clinical situations is Glucose Baxter typically used?+
What monitoring is required during Glucose Baxter infusion?+
Can Glucose Baxter cause fluid overload?+
What are common side effects of intravenous glucose solutions?+
Are there any serious adverse reactions associated with Glucose Baxter?+
Should Glucose Baxter be avoided with insulin therapy?+
Is Glucose Baxter safe for patients with renal disease?+
What precautions are needed for patients with known glucose allergies?+
Can Glucose Baxter be mixed with other IV medications?+
Is Glucose Baxter an over‑the‑counter product?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo